Eli Lilly updates EVP Brown’s 7,045.237-share stake
Amended Form 3 for Eli Lilly EVP Adrienne S. Brown corrects common stock holdings and details outstanding restricted stock units.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3/A
Rhea-AI Filing Summary
ELI LILLY & Co (LLY) filed an amended initial insider ownership report for Adrienne S. Brown, EVP and President LLY Immunology. The amendment corrects the previously reported direct holding of common stock to 7,045.237 shares and lists several direct holdings of restricted stock units, each representing a contingent right to receive one share of common stock at future dates.
Insider Trade Summary
5 transactions reported
Mixed
5 txns
Insider
Brown Adrienne S
Role
EVP, President LLY Imm
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Restricted Stock Unit F2 | -- | -- | -- |
| holding | Restricted Stock Unit F2 | -- | -- | -- |
| holding | Restricted Stock Unit F2 | -- | -- | -- |
| holding | Restricted Stock Unit F2 | -- | -- | -- |
| holding | Common Stock F1 | -- | -- | -- |
Holdings After Transaction:
Restricted Stock Unit — 3,669.091 contracts (Direct);
Common Stock — 7,045.237 shares (Direct)
Footnotes (2)
- F1. Corrects the number of shares previously reported to account for additional shares that were unintentionally omitted from the original Form 3 filing, and subsequent Forms 4.
- F2. Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
Key Figures
Direct common stock holdings: 7,045.237 shares
RSU underlying shares expiring February 16, 2026: 391 shares
RSU underlying shares expiring November 1, 2026: 2,530 shares
+2 more
5 metrics
Direct common stock holdings
7,045.237 shares
Directly held by Adrienne S. Brown following correction as of November 7, 2025
RSU underlying shares expiring February 16, 2026
391 shares
Restricted stock units convertible into Eli Lilly common stock
RSU underlying shares expiring November 1, 2026
2,530 shares
Restricted stock units convertible into Eli Lilly common stock
RSU underlying shares expiring February 16, 2027
394 shares
Restricted stock units convertible into Eli Lilly common stock
RSU underlying shares expiring February 16, 2028
354.091 shares
Restricted stock units convertible into Eli Lilly common stock
Key Terms
Restricted Stock Unit, contingent right, Form 3, Forms 4
4 terms
Restricted Stock Unit financial
"Each restricted stock unit represents a contingent right to receive one share"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
contingent right financial
"represents a contingent right to receive one share of Eli Lilly"
Form 3 regulatory
"omitted from the original Form 3 filing, and subsequent Forms 4."
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.
Forms 4 regulatory
"omitted from the original Form 3 filing, and subsequent Forms 4."
A Form 4 is a regulatory filing that company insiders—such as executives, directors, or large shareholders—must file to report purchases, sales, or other changes in their ownership of the company’s stock. Think of it as a public receipt or scoreboard showing when people closest to the company trade its shares; investors use it to gauge insiders’ confidence, spot potential conflicts of interest, or detect unusual trading activity that might influence investment decisions.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the amended Form 3/A for LLY disclose about Adrienne S. Brown?
It discloses that Adrienne S. Brown, EVP and President LLY Immunology, directly holds 7,045.237 shares of Eli Lilly common stock and several tranches of restricted stock units, each convertible into one share of common stock at specified future dates.
What restricted stock units are reported for Adrienne S. Brown in LLY’s Form 3/A?
The filing lists multiple direct holdings of restricted stock units, each representing a contingent right to receive one share of Eli Lilly common stock, with underlying share amounts such as 391, 2,530, 394, and 354.091 tied to expiration dates from 2026 through 2028.
Does the LLY Form 3/A mention a Rule 10b5-1 trading plan for Adrienne S. Brown?
No. There is no Rule 10b5-1 trading plan indicated in the amendment, and the structured data show no transactions executed under such a pre-arranged trading plan in this filing.
What correction is described in the footnotes of the LLY Form 3/A?
A footnote states that the amendment corrects the number of shares previously reported to account for additional shares that were unintentionally omitted from the original Form 3 and subsequent Forms 4, updating Brown’s reported common stock holdings.
AI-generated analysis. How Rhea-AI works. Not financial advice.
